Skip to content
OpenCapital
Earnings
Screener
Charts
Portfolio
Pricing
Connect your AI
Get started
Toggle navigation menu
Supernus Pharmaceuticals
SUPN
Revenue recognized that was included in deferred income at the beginning of the period
Revenue recognized that was included in deferred income at the beginning of the period at other companies
HTF
Heartflow, Inc. Common Stock
HTFL
$89K
+166%
Paycom Software
PAYC
$9M
-5.3%
ePlus
PLUS
$24M
+57.9%
AbCellera Biologics Inc.
ABCL
$7.9M
+204%
Rackspace Technology, Inc.
RXT
$60.1M
+21.2%
Q2 Holdings
QTWO
$76.8M
+17.4%
Other financials
Income statement
See full
Revenue
$207.7M
+38.6%
Gross profit
$184.3M
+37.5%
Operating income
-$8.3M
+18.8%
Net income
-$2.3M
+80.6%
EPS (diluted)
-$0.04
+81.0%
Balance sheet
See full
Cash & equivalents
$186.3M
+60.8%
Total debt
$40.9M
+26.6%
Total equity
$1.1B
+4.5%
Total assets
$1.5B
+11.4%
Cash flow
See full
Operating cash flow
$66.5M
+117%
CapEx
-
-100%
Free cash flow
$66.5M
+120%
Valuation
See full
Market cap
$2.58B
+62.8%
Enterprise value
$2.44B
+62.3%
P/S
3.3×
+0.9×
Profitability
See full
Gross margin
89.4%
+1.0pp
Operating margin
-7.8%
-18.9pp
Net margin
-3.7%
-13.0pp
FCF margin
27.9%
+3.4pp
Returns & leverage
See full
Return on equity
-2.8%
-9.1pp
Debt / equity
0×
0.0×
Current ratio
2×
-0.5×